Flora Peyvandi Shares Study on Anticoagulants and Ischemic Stroke Risk in Cancer-Associated VTE
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism.
Ischemic stroke is a common occurrence after cancer-associated VTE and may occur more frequently in patients treated with DOACs.”
Title: Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism
Authors: Sirui Ma, Yu-Cheng Chang, Cho Han Chiang, Junmin Song, Yu-Che Lee, Ko-Yun Chang, Robert A Redd, Thita Chiasakul, Ellen P. McCarthy, Jeffrey I. Zwicker, Rushad Patell, Avi Leader
Read the full article here.
Stay informed with Hemostasis Today.
-
Jan 23, 2026, 17:17Michael Makris on Japan’s Breakthrough FVIII Variants for Hemophilia A
-
Jan 23, 2026, 17:06Wolfgang Miesbach: HOPE-B Challenges 20 Years of Exclusion Criteria
-
Jan 23, 2026, 16:56Oliver Tiebel: Great and Unique Compilation of Current Knowledge on VWD
-
Jan 23, 2026, 16:46Soumya Mukherjee on Amyloid-β Isoform Modifications in CAA and Alzheimer’s
-
Jan 23, 2026, 16:32Amit Srivastava Edits The New Springer Protocols Volume on Extracellular Vesicles
-
Jan 23, 2026, 14:42David Stegner on PITTs Exacerbating Severe Inflammation
-
Jan 23, 2026, 14:30Christian Schulze: Time to Say Good-Bye to The “Obesity Paradox”?
-
Jan 23, 2026, 14:16Ahmed Nasreldein In The 1st Podcast Episode of International Journal of Stroke
-
Jan 23, 2026, 13:53Omar Shaltout: When Hematology Meets Gastroenterology in the ICU